- Home
- AUTL vs ETJ Comparison
AUTL vs ETJ Comparison
Compare AUTL & ETJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- ETJ
- Stock Information
- Founded
- AUTL 2014
- ETJ 2007
- Country
- AUTL United Kingdom
- ETJ United States
- Employees
- AUTL N/A
- ETJ N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- ETJ Finance Companies
- Sector
- AUTL Health Care
- ETJ Finance
- Exchange
- AUTL Nasdaq
- ETJ Nasdaq
- Market Cap
- AUTL 609.4M
- ETJ 623.9M
- IPO Year
- AUTL 2018
- ETJ N/A
- Fundamental
- Price
- AUTL $2.22
- ETJ $9.22
- Analyst Decision
- AUTL Strong Buy
- ETJ
- Analyst Count
- AUTL 3
- ETJ 0
- Target Price
- AUTL $10.20
- ETJ N/A
- AVG Volume (30 Days)
- AUTL 1.4M
- ETJ 175.6K
- Earning Date
- AUTL 03-13-2025
- ETJ 01-01-0001
- Dividend Yield
- AUTL N/A
- ETJ 8.30%
- EPS Growth
- AUTL N/A
- ETJ N/A
- EPS
- AUTL N/A
- ETJ N/A
- Revenue
- AUTL $10,091,000.00
- ETJ N/A
- Revenue This Year
- AUTL $851.83
- ETJ N/A
- Revenue Next Year
- AUTL $264.18
- ETJ N/A
- P/E Ratio
- AUTL N/A
- ETJ N/A
- Revenue Growth
- AUTL 82.71
- ETJ N/A
- 52 Week Low
- AUTL $2.07
- ETJ $7.20
- 52 Week High
- AUTL $7.37
- ETJ $8.47
- Technical
- Relative Strength Index (RSI)
- AUTL 38.18
- ETJ 47.19
- Support Level
- AUTL $2.18
- ETJ $9.07
- Resistance Level
- AUTL $2.38
- ETJ $9.24
- Average True Range (ATR)
- AUTL 0.16
- ETJ 0.12
- MACD
- AUTL 0.01
- ETJ -0.01
- Stochastic Oscillator
- AUTL 7.94
- ETJ 39.47
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About ETJ Eaton Vance Risk-Managed Diversified Equity Income Fund of Beneficial Interest
Eaton Vance Risk-Managed Diversified Equity Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income and gains, with a secondary objective of capital appreciation. The group invests in various sectors such as financials, healthcare, consumer discretionary, consumer staples, industrials, energy, utilities, telecommunication services, and materials.